ADVFN - Advanced Financial Network.
HOME» NYSE » G » GSK Stock Price » GSK Stock News

Glaxosmithkline Share News

 Glaxosmithkline Stock Price
GSK Stock Price
 Glaxosmithkline Stock Chart
GSK Stock Chart
 Glaxosmithkline Stock News
GSK Stock News
 Glaxosmithkline Company Information
GSK Company Information
 Glaxosmithkline Stock Trades
GSK Stock Trades

GlaxoSmithKline Buys Back 400,000 Shares

LONDON--GlaxoSmithKline PLC (GSK.LN) Monday announced it purchased 400,000 ordinary shares, to hold in treasury, on Aug. 6. MAIN FACTS: -Highest price paid per share was 1509.5 pence per share. -Lowest price paid per share was 1487 pence per share. -Shares on Monday closed at 1505 pence. -Write to Tapan Panchal at Subscribe to WSJ:

Stock News for Glaxosmithkline (GSK)
07/01/201611:42:55Report of Foreign Issuer (6-k)
07/01/201607:04:54Report of Foreign Issuer (6-k)
06/30/201608:13:00GlaxoSmithKline Starts Phase-1 for Antibody Clinical Trial
06/20/201608:29:17Report of Foreign Issuer (6-k)
06/20/201603:02:00GlaxoSmithKline COPD Triple Combination Study Shows Improved...
06/14/201607:40:00Technical Recap on Drug Manufacturers - Major Equities - Bristol-Myers...
06/14/201606:36:00GlaxoSmithKline Vaccines Unit Chairman to Retire Next Year
06/14/201606:18:12Report of Foreign Issuer (6-k)
06/10/201613:13:47Report of Foreign Issuer (6-k)
06/10/201612:24:49Report of Foreign Issuer (6-k)
06/10/201609:15:00ViiV Healthcare Announces FDA Approval to Lower the Weight Limit...
06/10/201609:15:00ViiV Healthcare Announces FDA Approval to Lower the Weight Limit...
06/08/201618:22:00ADRs End Mostly Higher; Bradesco, Petrobras Rise
06/08/201607:52:00GlaxoSmithKline Says Phase-3 Study for Sirukumab Meets Main Targets
06/08/201607:49:12Report of Foreign Issuer (6-k)
06/02/201611:00:00Regulatory update on US filing plans for closed triple combination...
06/02/201607:07:59Report of Foreign Issuer (6-k)
06/02/201602:42:00GlaxoSmithKline Sees US Regulatory Therapy Submission by End...
06/01/201608:00:00Regulus Expands Clinical Trial Collaboration with GSK
06/01/201607:43:57Report of Foreign Issuer (6-k)

Glaxosmithkline and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations